Clariant is excited to present the company’s latest portfolio of
India is on track to potentially account for 8-10% of
Indian Pharma Industry Expected to See 8.5% Revenue Growth Driven by Domestic and US Markets
Axis Securities Report Highlights Positive Trends for Q2 FY25 The Indian pharmaceutical industry is poised for a robust year, with revenue growth projected at 8.5%